Michael Sweeting works in Vascular Medicine affiliated with AstraZeneca (United Kingdom).
Dr. Michael Sweeting is a biostatistician serving as Director of Statistical Innovation at GSK, with a verified affiliation through his Google Scholar profile. He holds an honorary fellowship in the Department of Population Health Sciences at the University of Leicester. His work includes collaborations with institutions like AstraZeneca and involvement in major trials on aortic diseases at NHS hospitals such as St George's and St Thomas'.
234 pubs · 16,561 cites · h-index 61
MSc in Medical Statistics
University of Leicester
2000
PhD in Medical Statistics
University of Cambridge
2007
GSK
2025 - Present
AstraZeneca
2021 - 2025
University of Leicester
2018 - 2021
University of Cambridge
2013 - 2017
St George's University Hospitals NHS Foundation Trust
2001 - 2002